Soft JAK Inhibitors

According to its latest press release, Aclaris Therapeutics will be launching a phase 2 trial for the use of JAK inhibitors in androgenic alopecia (pattern hair loss) within the next few months.  Here’s the line item from the press release about Aclaris’ trial in androgenic alopecia. AGA-201 Topical – a planned Phase 2 open-label clinical trial…